B. Kupfer

CIRCULATING T CELL SUBSET WITH A REVERSIBLE E-ROSSETTING CAPACITY IN BREAST CANCER AND ITS ROLE IN CELL MEDIATED IMMUNITY

C. Moroz, S. Giler, B. Kupfer, 1979 .

Circulating human T cell subset with a reversible E-rossetting capacity in cancer and normals-hypothesis on the regulatory mechanism influencing their role in CMI.

C. Moroz, S. Giler, B. Kupfer, 1979, Advances in experimental medicine and biology.

Comparison of transferrin receptors, iron content and isoferritin profile in normal and malignant human breast cell lines.

C. Moroz, B. Kupfer, N. Shterman, 1991, Pathobiology : journal of immunopathology, molecular and cellular biology.

Preparation and characterization of monoclonal antibodies specific to placenta ferritin.

B. Parhami-Seren, C. Moroz, B. Kupfer, 1985, Clinica chimica acta; international journal of clinical chemistry.

Placental isoferritin as a physiological downregulator of cellular immunoreactivity during pregnancy.

L. Sirota, C. Moroz, B. Kupfer, 1989, Clinical and experimental immunology.

De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.

A. de Vries, O. Sperling, S. Brosh, 1976, The Journal of clinical investigation.

Expression of messenger RNA species coding for a Mr 43,000 peptide associated with ferritin in human leukemia-K562 cells and its down regulation during differentiation.

C. Moroz, B. Kupfer, N. Shterman, 1989, Cancer research.

Regulation of de novo purine synthesis in human and rat tissue: role of oxidative pentose phosphate pathway activity and of ribose-5-phosphate and phosphoribosylpyrophosphate availability.

A. De vries, B. Lipstein, O. Sperling, 1977, Advances in experimental medicine and biology.

Two T lymphocyte subpopulations isolated from human peripheral blood following "in vitro" treatment with adenosine.

H. Bessler, M. Djaldetti, C. Moroz, 1980, Biomedicine / [publiee pour l'A.A.I.C.I.G.].